Wilhelm Weihofen, Center for Proteomic Chemistry
Wilhelm Weihofen, Center for Proteomic Chemistry

Simon Moroney, D.Phil.

Board member since February 28, 2020

Simon Moroney, D.Phil.

Board member since February 28, 2020

Wilhelm Weihofen, Center for Proteomic Chemistry

Nationality: German/New Zealander | Year of birth: 1959

As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master of Science in chemistry.

Professional experience

  • Co-founder and CEO, MorphoSys AG, Germany (1992–2019)
  • Research associate, Department of Pharmacology, University of Cambridge, UK (1991–1992)
  • Assistant professor, Department of Chemistry, University of British Columbia, Canada (1989–1990)

Education

  • Doctorate in chemistry, University of Oxford, UK
  • Master of Science in chemistry, University of Waikato, New Zealand

Mandates

  • Chairman of the board of directors, Biotalys NV, Belgium

Key skills

  • Medicine/healthcare/R&D
  • Leadership/management
  • Law/regulatory/risk management

Source URL: https://www.novartis.com/about/board-directors/simon-moroney

List of links present in page